What does an absolute eosinophil count of 300–310 cells/µL on a complete blood count with differential suggest?

Normal to Mildly Elevated Eosinophil Count

An absolute eosinophil count (AEC) of 300-310 cells/µL falls within the normal to mildly elevated range and typically does not require immediate investigation in asymptomatic patients without specific risk factors.

Clinical Interpretation

This AEC level sits at the upper boundary of normal reference ranges. Recent population-based data shows that in healthy adults without asthma, COPD, or clinical allergy, the 95th percentile (upper limit of normal) ranges from 300-400 cells/µL depending on age 1. In the general adult population, median values are approximately 100-120 cells/µL, with the 95th percentile reaching 310-330 cells/µL 2.

Key Contextual Factors That Influence This Level

Your interpretation must account for:

• Age: Values of 300-310 cells/µL are more common in younger individuals (≤18 years have 2.4x higher odds of elevated counts) 2
• Sex: Males typically have slightly higher counts than females (median 120 vs 100 cells/µL) 2
• Atopy/Allergy: Clinical allergy and atopy significantly elevate baseline eosinophil counts 1, 2
• Smoking status: Current smokers have 1.7x higher odds of elevated counts 2
• Obesity and metabolic factors: Both independently associated with higher eosinophil levels 1, 2

When to Investigate Further

Do NOT pursue extensive workup if:

• Patient is asymptomatic
• No travel history to tropical/endemic regions
• No concerning symptoms (fever, weight loss, abdominal pain, neurological symptoms)
• No immunosuppression or planned immunosuppressive therapy

DO investigate if:

1. Travel/migration history from tropical regions - Even mild eosinophilia warrants helminth screening in returning travelers or migrants, as parasitic infections are diagnosed in 10-73% of such patients with eosinophilia 3. Key investigations include:

   • Concentrated stool microscopy (×3 samples)
   • Schistosomiasis serology (if freshwater exposure in endemic areas)
   • Strongyloides serology (critical before any immunosuppression)

2. Planned immunosuppression - Must exclude Strongyloides stercoralis, which can cause fatal hyperinfection syndrome decades after exposure 3

3. Respiratory disease context - In COPD patients, AEC ≥300 cells/µL predicts increased exacerbation risk (rate ratio 1.25-1.32) and may guide inhaled corticosteroid therapy 4, 5, 6

4. Progressive elevation on serial testing - Rising counts warrant investigation

Common Pitfalls to Avoid

• Don't over-investigate isolated mild elevations in patients with atopy, asthma, or allergic conditions - this is their baseline
• Don't miss parasitic screening in anyone with tropical exposure, even if asymptomatic and years after travel (Strongyloides can persist 50+ years) 3
• Don't assume a single normal value excludes parasites - eosinophilia may be transient during tissue migration phases, and stool microscopy may be negative during pre-patent periods 3

Threshold for Hematology Referral

Hematology referral is NOT indicated at this level. Recent data demonstrates that an AEC threshold of ≥1,500 cells/µL has 97% sensitivity for clinically meaningful eosinophilia requiring hematologic intervention 7. At 300-310 cells/µL, the likelihood of primary hematologic disease or hypereosinophilic syndrome is extremely low.